These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21357724)

  • 1. Identification of cytokeratin 18 as a biomarker of mouse and human hepatosplenic schistosomiasis.
    Manivannan B; Rawson P; Jordan TW; Karanja DM; Mwinzi PN; Secor WE; La Flamme AC
    Infect Immun; 2011 May; 79(5):2051-8. PubMed ID: 21357724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential patterns of liver proteins in experimental murine hepatosplenic schistosomiasis.
    Manivannan B; Rawson P; Jordan TW; Secor WE; La Flamme AC
    Infect Immun; 2010 Feb; 78(2):618-28. PubMed ID: 19933830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic changes at 8 weeks after infection are associated with chronic liver pathology in experimental schistosomiasis.
    Manivannan B; Jordan TW; Secor WE; La Flamme AC
    J Proteomics; 2012 Mar; 75(6):1838-48. PubMed ID: 22245420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two distinct pathological syndromes in male CBA/J inbred mice with chronic Schistosoma mansoni infections.
    Henderson GS; Nix NA; Montesano MA; Gold D; Freeman GL; McCurley TL; Colley DG
    Am J Pathol; 1993 Mar; 142(3):703-14. PubMed ID: 8456934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schistosoma mansoni: relationship of tumor necrosis factor-alpha to morbidity and collagen deposition in chronic experimental infection.
    Adewusi OI; Nix NA; Lu X; Colley DG; Secor WE
    Exp Parasitol; 1996 Nov; 84(2):115-23. PubMed ID: 8932761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features of hepatosplenic schistosomiasis in children.
    Abdurrahman MB; Attah B; Narayana PT
    Ann Trop Paediatr; 1981 Mar; 1(1):5-11. PubMed ID: 6185045
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum osteopontin is a biomarker of severe fibrosis and portal hypertension in human and murine schistosomiasis mansoni.
    Pereira TA; Syn WK; Pereira FE; Lambertucci JR; Secor WE; Diehl AM
    Int J Parasitol; 2016 Dec; 46(13-14):829-832. PubMed ID: 27729270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatosplenic schistosomiasis in Kenya: an assessment of the enzyme-linked immunosorbent assay (ELISA).
    de Cock KM; Hodgen AN; Lillywhite JE; Siongok TK; Lucas SB; Rees PH
    Trop Geogr Med; 1985 Dec; 37(4):285-90. PubMed ID: 4095765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 deficit correlates with chronic, hypersplenomegaly syndrome in male CBA/J mice infected with Schistosoma mansoni.
    Bosshardt SC; Freeman GL; Secor WE; Colley DG
    Parasite Immunol; 1997 Aug; 19(8):347-53. PubMed ID: 9292893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical recognition of mild hepatic schistosomiasis in an endemic area.
    Mackenjee MK; Coovadia HM; Chutte CH
    Trans R Soc Trop Med Hyg; 1984; 78(1):13-5. PubMed ID: 6710566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early responses associated with chronic pathology in murine schistosomiasis.
    Cêtre-Sossah CB; Montesano MA; Freeman GL; Willard MT; Colley DG; Secor WE
    Parasite Immunol; 2007 May; 29(5):241-9. PubMed ID: 17430547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of connective tissue metabolites in Schistosoma mansoni related liver disease.
    Kardorff R; Mugashe C; Gabone RM; Mahlert C; Doehring E
    Acta Trop; 1999 Jul; 73(2):153-64. PubMed ID: 10465055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoregulatory idiotypes stimulate T helper 1 cytokine responses in experimental Schistosoma mansoni infections.
    Montesano MA; Freeman GL; Secor WE; Colley DG
    J Immunol; 1997 Apr; 158(8):3800-4. PubMed ID: 9103446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Schistosomiasis SpleenOME: Unveiling the Proteomic Landscape of Splenomegaly Using Label-Free Mass Spectrometry.
    Cosenza-Contreras M; de Oliveira E Castro RA; Mattei B; Campos JM; Gonçalves Silva G; de Paiva NCN; de Oliveira Aguiar-Soares RD; Carneiro CM; Afonso LCC; Castro-Borges W
    Front Immunol; 2018; 9():3137. PubMed ID: 30728824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathogenesis and immunoregulation in schistosomiasis. Distinct chronic pathologic syndromes in CBA/J mice.
    Freeman GL; Montesano MA; Secor WE; Colley DG; Howard MJ; Bosshardt SC
    Ann N Y Acad Sci; 1996 Oct; 797():151-65. PubMed ID: 8993359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative imbalance between T regulatory cells and activated T cells in mice with differential morbidity in chronic Schistosoma mansoni infections.
    Watanabe K; Carter JM; Neely-Burnam M; Colley DG
    Parasite Immunol; 2009 Aug; 31(8):440-6. PubMed ID: 19646208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatosplenic schistosomiasis mansoni: ultrasound manifestations.
    Cerri GG; Alves VA; Magalhães A
    Radiology; 1984 Dec; 153(3):777-80. PubMed ID: 6387793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic schistosomiasis with massive splenomegaly: a case report and literature review.
    Thijs L; Messiaen P; van der Hilst J; Madoe V; Melis C; Van Eyken P; Vanmoerkerke I; Janssens F
    Acta Gastroenterol Belg; 2018; 81(1):93-96. PubMed ID: 29562382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal idiotypic exposure alters subsequent cytokine, pathology, and survival patterns in experimental Schistosoma mansoni infections.
    Montesano MA; Colley DG; Eloi-Santos S; Freeman GL; Secor WE
    J Exp Med; 1999 Feb; 189(4):637-45. PubMed ID: 9989978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic schistosomiasis.
    Bica I; Hamer DH; Stadecker MJ
    Infect Dis Clin North Am; 2000 Sep; 14(3):583-604, viii. PubMed ID: 10987111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.